These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3316981)

  • 41. TGF beta inhibits Go/S-phase transition in primary fibroblasts. Loss of response to the antigrowth effect of TGF beta is observed after immortalization.
    Sorrentino V; Bandyopadhyay S
    Oncogene; 1989 May; 4(5):569-74. PubMed ID: 2498805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell adhesion induces expression of growth-associated genes in suspension-arrested fibroblasts.
    Dike LE; Farmer SR
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6792-6. PubMed ID: 3045824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttranscriptional changes in growth factor-inducible gene regulation caused by antiproliferative interferons.
    Levine RA; Seshadri T; Hann SR; Campisi J
    Cell Regul; 1990 Jan; 1(2):215-26. PubMed ID: 2100198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microinjected c-myc as a competence factor.
    Kaczmarek L; Hyland JK; Watt R; Rosenberg M; Baserga R
    Science; 1985 Jun; 228(4705):1313-5. PubMed ID: 4001943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.
    Nishikura K; Murray JM
    Mol Cell Biol; 1987 Feb; 7(2):639-49. PubMed ID: 3547078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.
    Kelly K; Cochran BH; Stiles CD; Leder P
    Cell; 1983 Dec; 35(3 Pt 2):603-10. PubMed ID: 6606489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of c-myc and c-fos proto-oncogene expression by animal cell growth factors.
    Rollins BJ; Stiles CD
    In Vitro Cell Dev Biol; 1988 Feb; 24(2):81-4. PubMed ID: 3125143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell cycle progression of C3H 10T1/2 and 3T3 cells in the absence of an increase in c-myc RNA levels.
    Chang JD; Kennedy AR
    Carcinogenesis; 1988 Jan; 9(1):17-20. PubMed ID: 2446795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
    Damen JE; Greenberg AH; Wright JA
    Biochim Biophys Acta; 1991 Sep; 1097(2):103-10. PubMed ID: 1911883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells.
    Zullo JN; Cochran BH; Huang AS; Stiles CD
    Cell; 1985 Dec; 43(3 Pt 2):793-800. PubMed ID: 3000615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.
    Sabourin LA; Hawley RG
    J Cell Physiol; 1990 Dec; 145(3):564-74. PubMed ID: 1703172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T; Bravo R; Müller R
    Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.
    Campisi J; Gray HE; Pardee AB; Dean M; Sonenshein GE
    Cell; 1984 Feb; 36(2):241-7. PubMed ID: 6692471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle.
    Godwin AK; Lieberman MW
    Mol Carcinog; 1991; 4(4):275-85. PubMed ID: 1872950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors.
    Werner S; Roth WK; Bates B; Goldfarb M; Hofschneider PH
    Oncogene; 1991 Nov; 6(11):2137-44. PubMed ID: 1658709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.
    Thompson CB; Challoner PB; Neiman PE; Groudine M
    Nature; 1985 Mar 28-Apr 3; 314(6009):363-6. PubMed ID: 3982504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells.
    Zhan X; Hu X; Friesel R; Maciag T
    J Biol Chem; 1993 May; 268(13):9611-20. PubMed ID: 7683656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell cycle-dependent gene expression in V point-arrested BALB/c-3T3 cells.
    Olson JE; Winston JT; Whitlock JA; Pledger WJ
    J Cell Physiol; 1993 Feb; 154(2):333-42. PubMed ID: 8425914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor.
    Einat M; Resnitzky D; Kimchi A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7608-12. PubMed ID: 2415966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.